Korea United Pharm Inc. (KRX:033270)

Market Cap	304.56B +14.3%
Revenue (ttm)	161.44B +8.0%
Net Income	20.02B +21.0%
EPS	1,260.76 +24.3%
Shares Out	14.71M
PE Ratio	16.42
Forward PE	7.59
Dividend	450.00 (2.21%)
Ex-Dividend Date	Dec 29, 2025

Volume	54,552
Average Volume	35,354
Open	20,400
Previous Close	20,350
Day's Range	20,350 - 20,950
52-Week Range	18,080 - 22,450
Beta	0.46
RSI	71.50
Earnings Date	Feb 27, 2026

About Korea United Pharm

Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 665
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 033270

Financial Performance

In 2014, Korea United Pharm's revenue was 155.19 billion, an increase of 13.37% compared to the previous year's 136.89 billion. Earnings were 18.37 billion, an increase of 50.46%.